According to the recent research report titled ‘Asia Pacific Personal Protective Equipment for Infection Control Market Size By End-use, Product, Type, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, Asia Pacific personal protective equipment for infection control market is projected to amass USD 3 billion by 2026.
 

Growing cases of chronic diseases, outbreak of COVID-19 pandemic, strict regulations regarding occupational safety, increasing drug discovery, and other R&D activities are the key factors driving the growth of Asia Pacific personal protective equipment for infection control market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2759498/
 

Additionally, rising cognizance regarding infection control along with surging cases of infectious diseases will augment the demand for PPE (personal protective equipment) such as gloves, masks, and other products. Growing elderly population who are more prone to infections including coronavirus owing to low immunity power will boost the adoption for PPE.
 

Various regulatory authorities have imposed strict rules to ensure the safety of healthcare workers. Rising cognizance regarding workplace safety and regulations to prevent cross contamination in harmful environment will contribute to positive market outlook. In addition, favorable government initiatives to augment development of personal protective equipment amidst the pandemic situations like swine flu, Ebola virus, and COVID-19 will further accelerate the industry expansion.
 

Based on product terrain, the hand & arm segment held over 40% revenue share in the year 2019. The pandemic has increased the demand for gloves & elbows protector drastically for enhanced functioning of the healthcare workers. The protection of hand & arm is considered essential as infections are caused by pathogenic microorganism which are present on the skin. Growing importance of hand protection at the time of treatment will further accelerate the segmental growth over the analysis period.
 

Speaking of type, reusable PPE for infection control segment was worth USD 500 million in the year 2019. It can be used multiple times and offers long-term usage. The benefits such as cost-containment and durability over disposable equipment is likely to contribute to the segmental growth.
 

Elaborating on end-use scope, Asia Pacific personal protective equipment for infection control market from hospitals was remunerated at USD 1.1 billion in the year 2019 and is slated to grow substantially during the forecast timespan. Increasing number of patients admitted in hospitals on account of burgeoning chronic disorders and pandemic situations will create lucrative growth prospects for the industry players.  Besides, increasing healthcare expenditure by government will facilitate the segmental share.
 

From a regional perspective, Japan personal protective equipment for infection control industry is poised to register a decent growth through 2026. The growth is attributable to concentration of leading firms and developed healthcare infrastructure in the nation. Additionally, rising R&D activities in laboratories as well as institutes will further propel the demand for PPEs.
 

Major contenders in Asia Pacific personal protective equipment for infection control market are Kimberly-Clark Corporation, SHIELD Scientific, Medline Industries Inc., Cardinal Health Inc., B. Braun Melsungen AG, Dragerwerk AG, Ansell, Alpha Pro Tech Limited, The 3M Company, and Honeywell International.